2020 ASER/POQI共识声明:术后谵妄的预防

2020-01-31 美国促进恢复学会 Anesth Analg. 2020 Jan 31.

术后谵妄是一种老年综合征,主要表现为术后认知、注意力以及医师水平的变化。在大手术后高达50%的患者会发生,并与包括住院时间延长,费用增加和出院后继续住院率增加等不良结局相关。本文主要针对术后谵妄的预防提供循证指导建议。

中文标题:

2020 ASER/POQI共识声明:术后谵妄的预防

英文标题:

American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on Postoperative Delirium Prevention

发布机构:

美国促进恢复学会

发布日期:

2020-01-31

简要介绍:

术后谵妄是一种老年综合征,主要表现为术后认知、注意力以及医师水平的变化。在大手术后高达50%的患者会发生,并与包括住院时间延长,费用增加和出院后继续住院率增加等不良结局相关。本文主要针对术后谵妄的预防提供循证指导建议。

 

拓展指南:谵妄相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2020 ASER/POQI共识声明:术后谵妄的预防)] GetToolGuiderByIdResponse(projectId=1, id=127741c0018666c7, title=2020 ASER/POQI共识声明:术后谵妄的预防, enTitle=American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on Postoperative Delirium Prevention, guiderFrom=Anesth Analg. 2020 Jan 31., authorId=null, author=, summary=术后谵妄是一种老年综合征,主要表现为术后认知、注意力以及医师水平的变化。在大手术后高达50%的患者会发生,并与包括住院时间延长,费用增加和出院后继续住院率增加等不良结局相关。本文主要针对术后谵妄的预防提供循证指导建议。 , cover=, journalId=null, articlesId=null, associationId=1296, associationName=美国促进恢复学会, associationIntro=, copyright=0, guiderPublishedTime=Fri Jan 31 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<P>术后谵妄是一种老年综合征,主要表现为术后认知、注意力以及医师水平的变化。在大手术后高达50%的患者会发生,并与包括住院时间延长,费用增加和出院后继续住院率增加等不良结局相关。本文主要针对术后谵妄的预防提供循证指导建议。 </P> <P> </P>拓展指南:<strong>与<font color=red>谵妄</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=108841c001e666e0" title="重症患者谵妄管理专家共识" target=_blank>重症患者谵妄管理专家共识</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=2ffa91c00163020d" title="2018 SCCM临床实践指南:ICU内成人患者疼痛,躁动/镇静,谵妄,固定以及睡眠中断的管理" target=_blank>2018 SCCM临床实践指南:ICU内成人患者疼痛,躁动/镇静,谵妄,固定以及睡眠中断的管理</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=4e9091c00161591d" title="2018 ESMO临床实践指南:成人癌症患者谵妄的管理" target=_blank>2018 ESMO临床实践指南:成人癌症患者谵妄的管理</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=f24181c001ae7841" title="老年患者术后谵妄防治中国专家共识" target=_blank>老年患者术后谵妄防治中国专家共识</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=aef7c1c0013592a1" title="2017 ESA循证共识指南:术后谵妄" target=_blank>2017 ESA循证共识指南:术后谵妄</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E8%B0%B5%E5%A6%84" target=_blank>有关谵妄更多指南</a></ul>, tagList=[TagDto(tagId=50326, tagName=术后谵妄)], categoryList=[CategoryDto(categoryId=29, categoryName=麻醉疼痛科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=18959, appHits=429, showAppHits=25, pcHits=4660, showPcHits=16261, likes=12, shares=23, comments=11, approvalStatus=1, publishedTime=Sat Feb 22 20:47:05 CST 2020, publishedTimeString=2020-01-31, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Feb 22 20:47:05 CST 2020, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 21:40:35 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2020 ASER/POQI共识声明:术后谵妄的预防)])
2020 ASER/POQI共识声明:术后谵妄的预防
下载请点击:
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1069418, encodeId=24ea10694181b, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc195173625, createdName=146e07ebm78(暂无昵称), createdTime=Fri Nov 12 00:07:54 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996235, encodeId=b0bd99623579, content=积分?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ff2020307, createdName=1e20e69em33(暂无匿称), createdTime=Sun Jul 04 22:28:58 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996249, encodeId=7d56996249fc, content=不够, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ff2020307, createdName=1e20e69em33(暂无匿称), createdTime=Sun Jul 04 22:45:17 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971154, encodeId=63579e11542a, content=没积分。。。。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210605/a328dac9e3344d37b730d7626ff6f258/e4d432aa5b6a4989b356abce5bbaa68d.jpg, createdBy=37a85514166, createdName=MR.。Lu, createdTime=Sat Jun 05 17:06:45 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957841, encodeId=07c995e841c8, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210220/77330d7159f848b8b56fecea78274f48/393da69ff0a046349bd4f53b629db545.jpg, createdBy=74b45430660, createdName=嘉儿822, createdTime=Sat Apr 17 16:00:00 CST 2021, time=2021-04-17, status=1, ipAttribution=)]
    2021-11-12 146e07ebm78(暂无昵称)

    很好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1069418, encodeId=24ea10694181b, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc195173625, createdName=146e07ebm78(暂无昵称), createdTime=Fri Nov 12 00:07:54 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996235, encodeId=b0bd99623579, content=积分?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ff2020307, createdName=1e20e69em33(暂无匿称), createdTime=Sun Jul 04 22:28:58 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996249, encodeId=7d56996249fc, content=不够, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ff2020307, createdName=1e20e69em33(暂无匿称), createdTime=Sun Jul 04 22:45:17 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971154, encodeId=63579e11542a, content=没积分。。。。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210605/a328dac9e3344d37b730d7626ff6f258/e4d432aa5b6a4989b356abce5bbaa68d.jpg, createdBy=37a85514166, createdName=MR.。Lu, createdTime=Sat Jun 05 17:06:45 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957841, encodeId=07c995e841c8, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210220/77330d7159f848b8b56fecea78274f48/393da69ff0a046349bd4f53b629db545.jpg, createdBy=74b45430660, createdName=嘉儿822, createdTime=Sat Apr 17 16:00:00 CST 2021, time=2021-04-17, status=1, ipAttribution=)]
    2021-07-04 1e20e69em33(暂无匿称)

    积分?

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1069418, encodeId=24ea10694181b, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc195173625, createdName=146e07ebm78(暂无昵称), createdTime=Fri Nov 12 00:07:54 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996235, encodeId=b0bd99623579, content=积分?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ff2020307, createdName=1e20e69em33(暂无匿称), createdTime=Sun Jul 04 22:28:58 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996249, encodeId=7d56996249fc, content=不够, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ff2020307, createdName=1e20e69em33(暂无匿称), createdTime=Sun Jul 04 22:45:17 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971154, encodeId=63579e11542a, content=没积分。。。。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210605/a328dac9e3344d37b730d7626ff6f258/e4d432aa5b6a4989b356abce5bbaa68d.jpg, createdBy=37a85514166, createdName=MR.。Lu, createdTime=Sat Jun 05 17:06:45 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957841, encodeId=07c995e841c8, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210220/77330d7159f848b8b56fecea78274f48/393da69ff0a046349bd4f53b629db545.jpg, createdBy=74b45430660, createdName=嘉儿822, createdTime=Sat Apr 17 16:00:00 CST 2021, time=2021-04-17, status=1, ipAttribution=)]
    2021-07-04 1e20e69em33(暂无匿称)

    不够

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1069418, encodeId=24ea10694181b, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc195173625, createdName=146e07ebm78(暂无昵称), createdTime=Fri Nov 12 00:07:54 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996235, encodeId=b0bd99623579, content=积分?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ff2020307, createdName=1e20e69em33(暂无匿称), createdTime=Sun Jul 04 22:28:58 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996249, encodeId=7d56996249fc, content=不够, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ff2020307, createdName=1e20e69em33(暂无匿称), createdTime=Sun Jul 04 22:45:17 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971154, encodeId=63579e11542a, content=没积分。。。。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210605/a328dac9e3344d37b730d7626ff6f258/e4d432aa5b6a4989b356abce5bbaa68d.jpg, createdBy=37a85514166, createdName=MR.。Lu, createdTime=Sat Jun 05 17:06:45 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957841, encodeId=07c995e841c8, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210220/77330d7159f848b8b56fecea78274f48/393da69ff0a046349bd4f53b629db545.jpg, createdBy=74b45430660, createdName=嘉儿822, createdTime=Sat Apr 17 16:00:00 CST 2021, time=2021-04-17, status=1, ipAttribution=)]
    2021-06-05 MR.。Lu

    没积分。。。。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1069418, encodeId=24ea10694181b, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc195173625, createdName=146e07ebm78(暂无昵称), createdTime=Fri Nov 12 00:07:54 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996235, encodeId=b0bd99623579, content=积分?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ff2020307, createdName=1e20e69em33(暂无匿称), createdTime=Sun Jul 04 22:28:58 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996249, encodeId=7d56996249fc, content=不够, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ff2020307, createdName=1e20e69em33(暂无匿称), createdTime=Sun Jul 04 22:45:17 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971154, encodeId=63579e11542a, content=没积分。。。。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210605/a328dac9e3344d37b730d7626ff6f258/e4d432aa5b6a4989b356abce5bbaa68d.jpg, createdBy=37a85514166, createdName=MR.。Lu, createdTime=Sat Jun 05 17:06:45 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957841, encodeId=07c995e841c8, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210220/77330d7159f848b8b56fecea78274f48/393da69ff0a046349bd4f53b629db545.jpg, createdBy=74b45430660, createdName=嘉儿822, createdTime=Sat Apr 17 16:00:00 CST 2021, time=2021-04-17, status=1, ipAttribution=)]
    2021-04-17 嘉儿822

    很好

    0